Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laser Capture Microdissection | 1 | 2024 | 6 | 0.930 |
Why?
|
| Carotid Artery Diseases | 1 | 2013 | 33 | 0.450 |
Why?
|
| Molecular Imaging | 1 | 2013 | 53 | 0.440 |
Why?
|
| Microdissection | 2 | 2024 | 19 | 0.440 |
Why?
|
| Thiazolidines | 1 | 2011 | 5 | 0.390 |
Why?
|
| Histones | 1 | 2011 | 312 | 0.320 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 606 | 0.240 |
Why?
|
| Drug Discovery | 1 | 2024 | 85 | 0.220 |
Why?
|
| Neoplasms | 2 | 2024 | 1235 | 0.210 |
Why?
|
| Chromatography, Liquid | 1 | 2024 | 232 | 0.210 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 1171 | 0.210 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 66 | 0.210 |
Why?
|
| Mass Spectrometry | 1 | 2024 | 306 | 0.210 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 212 | 0.210 |
Why?
|
| Proteomics | 1 | 2024 | 329 | 0.190 |
Why?
|
| Macrophages | 2 | 2013 | 363 | 0.170 |
Why?
|
| Phosphorylation | 4 | 2019 | 535 | 0.170 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 88 | 0.160 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2019 | 43 | 0.160 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 53 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 197 | 0.150 |
Why?
|
| Thymus Gland | 1 | 2018 | 42 | 0.150 |
Why?
|
| Parathyroidectomy | 1 | 2018 | 45 | 0.150 |
Why?
|
| Oligopeptides | 1 | 2018 | 89 | 0.150 |
Why?
|
| Thyroidectomy | 1 | 2018 | 59 | 0.150 |
Why?
|
| DNA, Neoplasm | 1 | 2018 | 147 | 0.150 |
Why?
|
| Collagen | 1 | 2018 | 206 | 0.140 |
Why?
|
| Neoplasm, Residual | 1 | 2018 | 165 | 0.140 |
Why?
|
| Parathyroid Hormone | 1 | 2018 | 147 | 0.140 |
Why?
|
| Heptanoic Acids | 2 | 2013 | 34 | 0.140 |
Why?
|
| Mice | 6 | 2019 | 5739 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2019 | 214 | 0.140 |
Why?
|
| Pyrroles | 2 | 2013 | 69 | 0.140 |
Why?
|
| Microglia | 2 | 2013 | 141 | 0.120 |
Why?
|
| Lithium Chloride | 1 | 2013 | 6 | 0.110 |
Why?
|
| Ligation | 1 | 2013 | 59 | 0.110 |
Why?
|
| Cell Line | 2 | 2013 | 1000 | 0.110 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 56 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 56 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 40 | 0.110 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2012 | 34 | 0.100 |
Why?
|
| Monocytes | 1 | 2013 | 131 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 157 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 83 | 0.100 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 88 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 1403 | 0.100 |
Why?
|
| Animals | 6 | 2019 | 13187 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2013 | 264 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 138 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2013 | 841 | 0.090 |
Why?
|
| Glucose | 1 | 2013 | 344 | 0.090 |
Why?
|
| Apoptosis | 2 | 2019 | 1101 | 0.090 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2011 | 72 | 0.090 |
Why?
|
| Recombination, Genetic | 1 | 2011 | 96 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2012 | 452 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2011 | 231 | 0.090 |
Why?
|
| DNA Repair | 1 | 2011 | 193 | 0.090 |
Why?
|
| Humans | 6 | 2024 | 49974 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 976 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1376 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 396 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1007 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2019 | 1573 | 0.060 |
Why?
|
| Calcium | 2 | 2018 | 396 | 0.060 |
Why?
|
| Antigens | 1 | 2022 | 41 | 0.050 |
Why?
|
| Epitopes | 1 | 2022 | 59 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2022 | 62 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2022 | 36 | 0.050 |
Why?
|
| Paraffin Embedding | 1 | 2022 | 53 | 0.050 |
Why?
|
| Formaldehyde | 1 | 2022 | 52 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1174 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2022 | 453 | 0.050 |
Why?
|
| Genomics | 1 | 2022 | 286 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2019 | 7 | 0.040 |
Why?
|
| Female | 3 | 2019 | 26472 | 0.040 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2019 | 17 | 0.040 |
Why?
|
| Sumoylation | 1 | 2019 | 21 | 0.040 |
Why?
|
| DNA | 1 | 2022 | 541 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2019 | 1618 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 61 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2019 | 67 | 0.040 |
Why?
|
| Proline | 1 | 2018 | 30 | 0.040 |
Why?
|
| Colon | 1 | 2019 | 98 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 102 | 0.040 |
Why?
|
| Proteolysis | 1 | 2018 | 94 | 0.040 |
Why?
|
| Aorta | 1 | 2019 | 161 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 111 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 225 | 0.040 |
Why?
|
| Cell Movement | 1 | 2018 | 247 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 252 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2019 | 269 | 0.040 |
Why?
|
| Mutation | 1 | 2022 | 1294 | 0.030 |
Why?
|
| Genotype | 1 | 2018 | 537 | 0.030 |
Why?
|
| Bone Resorption | 1 | 2018 | 304 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 1455 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2013 | 29 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 82 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 96 | 0.030 |
Why?
|
| Pravastatin | 1 | 2012 | 18 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 1816 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 99 | 0.030 |
Why?
|
| Simvastatin | 1 | 2012 | 29 | 0.030 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2012 | 13 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 192 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 3305 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 12069 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2018 | 2929 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 13236 | 0.010 |
Why?
|
| Male | 1 | 2019 | 25241 | 0.010 |
Why?
|